Brief: Resapp Health Announces Increased Scheme Consideration From Pfizer

Raptor Metals

14/06/2022 06:41

June 14 (Reuters) - Resapp Health Ltd  RAP.AX :
    * INCREASED SCHEME CONSIDERATION FROM PFIZER
    * INCREASE SCHEME CONSIDERATION TO A$0.207 PER SHARE FROM
A$0.115
PER SHARE IN CASH 
    * CO, PFIZER AGREED TO INCREASE CONSIDERATION TO
A$0.146/SHARE IN
CASH IF CONFIRMATORY DATA READOUT CONDITION NOT SATISFIED
    * BOARD UNANIMOUSLY RECOMMENDS THAT RESAPP SHAREHOLDERS VOTE
IN
FAVOUR OF REVISED SCHEME
    * WILL INCREASE SCHEME CONSIDERATION TO A$0.207 PER SHARE IN
CASH,
IF CONFIRMATORY DATA READOUT CONDITION IS SATISFIED 

Source text for Eikon:  ID:nASXr7MXW 
Further company coverage:  RAP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))